Author(s):
Krishnaphanisri Ponnekanti, Ramreddy Godela, Rajendra Yagnambhatla
Email(s):
rgodela@gitam.edu , ramreddy.godela@gmail.com , krishnaphanisri@gmail.com
DOI:
10.52711/0974-360X.2024.00456 
Address:
Krishnaphanisri Ponnekanti1*, Ramreddy Godela2*, Rajendra Yagnambhatla3
1Malla Reddy Institute of Pharmaceutical Science, Maisammaguda, Dulapally, Medchal, India.
2GITAM School of Pharmacy, GITAM Deemed to be University, Hyderabad, India.
3Seven Hills College of Pharmacy (Autonomous),Venkatramapuram, Ramachandrapuram (Mandal), Tirupati, Andhrapradesh, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 6,
Year - 2024
ABSTRACT:
The primary goal of the proposed study was to establish and validate an efficient, sensitive, specific, and simple RP-UPLC method for concurrent analysis of Memantine and Donepezil in pure mixed powder and fixed-dose combined tablets. AQUITY UPLC instrument with TUV detector was selected to develop the present approach. To separate or resolute Memantine and Donepezil with significant system sutability, X bridge C18 column (100x 2.1mm,1.8m) and a mobile phase of KH2PO4: ACN (70:30 v/v) with 0.3mL/min flow rate were used. The eluted Memantine and Donepezil were detected at 257nm. The optimized approach was validated in consideration with ICH Q2R1 provisions. Forced degradation studies were carried out to confirm its stability indicating property of the optimized method was confirmed by implementing the forced degradation studies to Memantine and Donepezil solutions.The retention times of Memantine and Donepezil were observed at 1.17and 1.59min correspondingly. The Linearity was ensured for Memantine and Donepezil in the range 3.5-21µg/mL and 2.5-15 µg/mL correspondingly. The intraday and inter-day precision was confirmed by assessing %RSD, which resulted in the range of 0.23 to 1.03. The recovery of both Memantine and Donepezil in spiked samples was in the range of 99% - 100.30%. The obtained results confirming the established method’s specificity, sensitivity and competency. Investigation of Memantine and Donepezil in the incidence of several strained or forced environments confirms stability representing feature of the stated approach. The established RP-UPLC approach is enormously effective in separation and analysis of Memantine and Donepezil. Hence, the expected approach has significant credit in quality control unit of pharmaceutical segment.
Cite this article:
Krishnaphanisri Ponnekanti, Ramreddy Godela, Rajendra Yagnambhatla. Concurrent Quantification of Memantine and Donepezil via RP-UPLC with Stability Indicating Feature: Method Development and Validation. Research Journal of Pharmacy and Technology. 2024; 17(6):2907-4. doi: 10.52711/0974-360X.2024.00456
Cite(Electronic):
Krishnaphanisri Ponnekanti, Ramreddy Godela, Rajendra Yagnambhatla. Concurrent Quantification of Memantine and Donepezil via RP-UPLC with Stability Indicating Feature: Method Development and Validation. Research Journal of Pharmacy and Technology. 2024; 17(6):2907-4. doi: 10.52711/0974-360X.2024.00456 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-6-75
REFERENCES:
1. Gauthier S. Molinuevo JL. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease. Alzheimer's and Dementia. 2013; 9(3): 326-31. https://doi.org/10.1016/j.jalz.2011.11.005
2. Atri A. Molinuevo JL. Lemming O. Wirth Y. Pulte I. Wilkinson D. Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy. Alzheimer's Research and Therapy. 2013; 5(1): 1-1. https://doi.org/10.1186/alzrt160
3. Farrimond LE. Roberts E. McShane R. Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review. BMJ Open. 2012; 2(3): e000917. https://doi.org/10.1136/bmjopen-2012-000917
4. Molino I. Colucci L. Fasanaro AM. Traini E. Amenta F. Efficacy of memantine. donepezil or their association in moderate-severe Alzheimer’s disease: a review of clinical trials. The Scientific World Journal. 2013; 2013. https://doi.org/10.1155/2013/925702
5. Pappa H. Farru R. Vilanova PO. Palacios M. Pizzorno MT. A new HPLC method to determine Donepezil hydrochloride in tablets. Journal of Pharmaceutical and Biomedical Analysis. 2002; 27(1-2): 177-82. https://doi.org/10.1016/s0731-7085(01)00499-x
6. Singh BK. Srivastava RK. Kumar SS. Dutta PK. Stability-indicative HPLC determination of donepezil hydrochloride in tablet dosage form. Pharmaceutical Chemistry Journal. 2012; 45: 766-70. http://doi.org/10.1007/s11094-012-0721-4
7. Sastry BS. Gananadhamu S. Devadasu C. Balaji K. New RP-HPLC method for estimation of Donepezil Hydrochloride in pharmaceutical formulations. Int J Chem Sci. 2008; 6(4): 1976-1983.
8. Prakash Kumar B. Sharath HN (2016) Development and validation for estimation of Donepezil HCl from bulk and marketed dosage forms by using RP-HPLC. Int J Pharmacogn Phytochem Res. 2016; 7 (3): 343-349.
9. Kumar TS. Solairaj P. Thangathirupathi A. Analytical method development and validation of donepezil hydrochloride tablets by RP-HPLC. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(3): 62-5.
10. Barot TG. Patel PK. RP-HPLC Method for the estimation of Donepezil hydrochloride dosage form. Journal of Chemistry. 2009; 6: 594-600. http://dx.doi.org/10.1155/2009/532830
11. Al-Zoman NZ. Hefnawy MM. Al-Majed AR. Alanazi AM. Mostafa GA. Chiral Stability-Indicating HPLC Method For Analysis Of Donepezil In Pharmaceutical Formulations. Digest Journal of Nanomaterials and Biostructures (DJNB). 2013; 8(2).
12. Patel YK. Noolvi MN. Raj H. Patel MP. Development and validation of stability indicating reverse phase high performance liquid chromatographic method for estimation of Donepezil HCl from bulk drug. Asian Journal of Pharmaceutical Research. 2015; 5(2): 96-101. https://doi.org/10.5958/2231-5691.2015.00014.3
13. Ruela AL. Santos MG. Figueiredo EC. Pereira GR. LC-PDA and LC-MS studies of donepezil hydrochloride degradation behaviour in forced stress conditions. Journal of the Brazilian Chemical Society. 2014; 25: 2094-101. http://doi.org/10.5935/0103-5053.20140199
14. Sangshetti JN. Mahaparale PR. Paramane S. Shinde DB. Spectrophotometric estimation of donepezil hydrochloride in bulk and tablet formulation. Trends in Applied Sciences Research. 2008; 3(1): 109-12. http://d.doi.org/10.3923/tasr.2008.109.112
15. Yasir M. Sara U. Development of UV spectrophotometric method for the analysis of acetylcholinesterase inhibitor. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(9): 128-31.
16. Sharmila D. Swaminathan J. Method development and validation of Donepezil hydrochloride by using UV Spectrophotometric method. International Journal of Pharmaceutical Research and Bio-Science. 2019; 8(3): 1-9.
17. Shirwaikar A. Devi S. Rajagopal PL. Kiron SS. Sreejith KR. Development and validation of analytical method for determination of Donepezil hydrochloride in pure and dosage forms. Asian J Pharm Clin Res. 2014; 7(1): 149-53.
18. Ravi Kumar V. Chaitanya S. Sambasiva Rao A. Sreekiran M. Estimation of Donepezil hydrochloride by ion complex extractive spectrometry. International journal of Research in pharmacy and chemistry. 2011; 1(3): 512-8.
19. Jalalizadeh H. Raei M. Fallah Tafti R. Farsam H. Kebriaeezadeh A. Souri E. A stability-indicating HPLC method for the determination of memantine hydrochloride in dosage forms through derivatization with 1-fluoro-2. 4-dinitrobenzene. Scientia Pharmaceutica. 2014; 82(2): 265-80. https://doi.org/10.3797%2Fscipharm.1310-09
20. Narola B. Singh AS. Santhakumar PR. Chandrashekhar TG. A validated stability-indicating reverse phase HPLC assay method for the determination of memantine hydrochloride drug substance with UV-detection using precolumn derivatization technique. Analytical Chemistry Insights. 2010;5:ACI-S3936. https://doi.org/10.4137%2Faci.s3936
21. Patel KH. Patel SK. Karkhanis VV. Captain AD. Development and validation of analytical method for estimation of Memantine hydrochloride. Austin J Anal Pharm Chem. 2015; 2(4): 1047.
22. Anees A. Bahazeq AA. Rehman MU. Akbar S. Mehveen J. Development and validation of memantine hydrochloride by RP-HPLC method. Asian Journal of Pharmaceutical Research. 2019; 9(2): 69-74. https://doi.org/10.5958/2231-5691.2019.00011.X
23. Sawant TB. Mane DV. To develop HPLC method for the assay of memantine hydrochloride tablets using refractive index (RI) detector. Indo American Journal of Pharmaceutical Sciences. 2017 Nov 1; 4(11): 4391-7.
24. Rao TN. Silpa G. Srinivasarao T. New validated method for the determination of memantine hydrochloride content in tablet dosage forms by a high performance liquid chromatography with evaporative light scattering detector. Research Journal of Pharmacy and Technology. 2012; 5(10): 7.
25. Rao TN. Silpa G. Srinivasarao T. New validated method for the determination of memantine hydrochloride content in tablet dosage forms by a high performance liquid chromatography with evaporative light scattering detector. Research Journal of Pharmacy and Technology. 2012; Oct 1; 5(10): 7.
26. Ravisankar P. Rao GD. Devadasu C. A Novel Spectrofluorimetric Method For The Determination Of Memantine Hydrocloride In Bulk And Pharmaceutical Formulation. Int J Pharm Sci Res. 2014; 5(11): 4808-14. http://dx.doi.org/10.13040/IJPSR.0975-8232.5(11).4808-14
27. Michail K. Daabees H. Beltagy Y. Abdel-Khalek M. Khamis M. Spectrophotometric and spectrofluorimetric determination of memantine hydrochloride in bulk and pharmaceutical preparations. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(3): 180-5. http://doi.org/10.22159/ijap.2022v14i2.43924
28. Sujana K. Sankar DG. Abbulu K. Simultaneous Estimation of Donepezil and Memantine by Reverse Phase HPLC in Bulk and Pharmaceutical Dosage Form. Research Journal of Pharmacy and Technology. 2012; 5(7): 958-61.
29. Ravi Kumar R. Ganesh M. Jang H. Validated stability indicating simultaneous estimation of memantine and donepezil in pharmaceutical formulation by RP-HPLC-DAD. Pharm Lett. 2016; 8(15): 79-87.
30. Amena SN. Rizwan SH. Stability indicating analytical method development and validation of memantine and HCl and donepezil HCl using RP-HPLC. Int J Pharm Pharm Sci. 2015; 7(11): 204-10.
31. Nováková L. Solichová D. Solich P. Advantages of ultra performance liquid chromatography over high‐performance liquid chromatography: Comparison of different analytical approaches during analysis of diclofenac gel. Journal of separation science. 2006; 29(16): 2433-43. https://doi.org/10.1002/jssc.200600147
32. ICH. Quality Guidelines ICH. https://www.ich.org/page/quality-guidelines (accessed January 18. 2021).
33. Gandla K. Lalitha R. Bommakanti S. Suthakaran R. Pallavi K. Development and validation of RP-HPLC method for simultaneous estimation of albendazole and praziqantel in tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2015; 5(3): 115-8. http://doi.org/10.52711/2231-5659.2022.00032
34. Konidala SK. Penumala A. Mugada VK. Kamala GR. Development and validation of RP-HPLC method for simultaneous estimation of Paracetamol and Flupirtine Maleate. Asian Journal of Pharmaceutical Analysis. 2015; 5(2): 105-11. http://doi.org/10.5958/2231-5675.2015.00017.4
35. Mahalingam V. Vijayabaskar S. Kalaivani RA. Somanathan T. Analytical method development and validation for the analysis of donepezil hydrochloride and its related substances using ultra performance liquid chromatography. Research Journal of Pharmacy and Technology. 2017; 10(8): 2743-9. http://doi.org/10.5958/0974-360X.2017.00487.5
36. Sebaiy MM. El-Shanawany AA. El-Adl SM. Abdel-Aziz LM. Hashem HA. Rapid RP-HPLC method for simultaneous estimation of norfloxacin and tinidazole in tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2011; 1(4): 79-84.
37. Patel NK. Koradia SK. Development and Validation of stability indicating RP-HPLC method for the simultaneous estimation of Beclomethasone dipropionate and Formoterol fumarate in their combined pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2016; 6(2): 83-90. http://doi.org/10.5958/2231-5675.2016.00013.2
38. Blessy MR. Patel RD. Prajapati PN. Agrawal YK. Development of forced degradation and stability indicating studies of drugs—A review. Journal of Pharmaceutical Analysis. 2014; 4(3): 159-65. https://doi.org/10.1016/j.jpha.2013.09.003
39. Ngwa G. Forced degradation as an integral part of HPLC stability-indicating method development. Drug Delivery Technology. 2010; 10(5): 56-9. https://doi.org/10.1016/j.jpha.2013.09.003
40. Bhavya B. Nagaraju P. Mounika V. Priyadarshini GI. Stability indicating RP-HPLC method development and validation for simultaneous estimation of albendazole and ivermectin in pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2017; 7(1): 6-14. https://doi.org/10.5958/2231-5675.2017.00002.3
41. Joshi HV. Shah UA. Patel JK. Patel TR. Development and validation of stability indicating method for the simultaneous estimation of tamsulosin HCl and tolterodine tartrate in pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2019; 9(4): 205-9. https://doi.org/10.5958/2231-5675.2019.00034.6